Additional dexamethasone in chemotherapies with carboplatin and paclitaxel could reduce the impaired glycometabolism in rat models

BACKGROUND: Side-effects have been considered as the limitation of the chemotherapy agents’ administration and life quality in patients with ovarian cancers. In order to explore the influence of the chemotherapy agents commonly used in ovarian cancer patients on the blood glucose metabolism in rat m...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yanxiu, Zeng, Haoxia, Chang, Xiaohong, Wang, Chaohua, Cui, Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769515/
https://www.ncbi.nlm.nih.gov/pubmed/29338697
http://dx.doi.org/10.1186/s12885-017-3917-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769515/
https://www.ncbi.nlm.nih.gov/pubmed/29338697
http://dx.doi.org/10.1186/s12885-017-3917-x

Ejemplares similares